173
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond

, MD
Pages 999-1001 | Published online: 07 Apr 2011

Bibliography

  • Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000;12:1710-14
  • American Academy of Pain Medicine, American Pain Society. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and American Pain Society. Clin J Pain 1997;13:6-8
  • Trescot AM, Boswell MV, Atluri SL, Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9:1-39
  • National Center on Addiction and Substance Abuse (NCASA). Under the counter: the diversion and abuse of controlled prescription drugs in the United Sates. NCASA, New York; 2005
  • Substance Abuse Mental Health Services Administration (SAMSHA). National survey on drug use & health national results. SAMSHA, Services DoHaHm, Rockville, MD; 2007. Contract no.: DHHS Publication no. SMA 07-4293
  • FDA Consumer Health Information. Combating misuse and abuse of prescription drugs. FDA Consumer Health Information/US Food and Drug Administration, July 2010. Available from: http:/www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM220434.pdf [Last accessed 8 October 2010]
  • Jang DH, Rohe JC, Hoffman RS, Nelson LS. Severe opioid withdrawal due to misuse of new combined morphine and naltrexone product (Embeda). Ann Emerg Med 2010;55:303-4
  • Ruan X, Chen T, Gudin J, Acute opioid withdrawal precipitated by ingestion of crushed Embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature. J Opioid Manag 2010;6:300-3
  • Sloan P, Babul N. Extended-release opioids for the management of chronic non-malignant pain. Expert Opin Drug Deliv 2006;3:489-97

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.